Daily market insights on Telegram
Share Predictions

Stocks

Stock predictionsToday's rankings and AI sentiment SectorsWhere each part of the market leans Stock directoryEvery U.S. stock, A to Z AI trading portfolioA simulation of the predictions Penny stocks portfolioA simulation, for penny stocks

Options

Options chainCalls and puts for any U.S. stock Options predictionsEvery closed one, wins and losses Options directoryEvery optionable stock, A to Z Options guidesFrom Greeks to spreads, in plain words

Apps

SharePredsStocks OpPredsOptions CPredsCrypto TradeSimSimulator Average CostCalculator All apps

Tools

All trading tools Get SharePreds

Nektar Therapeutics (NKTR) stock analysis and AI prediction

The company facts of Nektar Therapeutics, with its price and AI prediction for the next 10 market days in SharePreds.

Keep looking in SharePreds

You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.

QR code that opens SharePreds in your phone's app storeScan with your phone
See all five apps
SharePreds ranking U.S. stocks by their chance of rising over the next 10 days

About Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Exchange
NASDAQ
Market value
$1.3 billion
Employees
63
Headquarters
SAN FRANCISCO, CA
Listed since
May 3, 1994
Website
nektar.com

NKTR questions

What is the AI prediction for NKTR stock?

Each market day our model rates Nektar Therapeutics (NKTR) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.

How often is the NKTR prediction updated?

Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.

What do Bullish, Neutral and Bearish mean?

Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.

Where can I see the exact likelihood for NKTR?

In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.

Where can I see NKTR options?

The NKTR options page opens its calls and puts, with price, volume, implied volatility and the Greeks.